Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem).

Clinical diagnosis Cognitive impairment Consensus criteria Dementia Dementia with Lewy bodies Diagnostic accuracy Diagnostic toolkits

Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 09 12 2021
accepted: 25 02 2022
pubmed: 5 3 2022
medline: 24 6 2022
entrez: 4 3 2022
Statut: ppublish

Résumé

Dementia with Lewy bodies (DLB) may represent a diagnostic challenge, since its clinical picture overlaps with other dementia. Two toolkits have been developed to aid the clinician to diagnose DLB: the Lewy Body Composite Risk Score (LBCRS) and the Assessment Toolkit for DLB (AT-DLB). We aim to evaluate the reliability of these two questionnaires, and their ability to enhance the interpretation of the international consensus diagnostic criteria. LBCRS and AT-DLB were distributed to 135 Italian Neurological Centers for Cognitive Decline and Dementia (CDCDs), with the indication to administer them to all patients with dementia referred within the subsequent 3 months. We asked to subsequently apply consensus criteria for DLB diagnosis, to validate the diagnostic accuracy of the two toolkits. A total of 23 Centers joined the study; 1854 patients were enrolled. We found a prevalence of possible or probable DLB of 13% each (26% total), according to the consensus criteria. LBCRS toolkit showed good reliability, with a Cronbach alpha of 0.77, stable even after removing variables from the construct. AT-DLB toolkit Cronbach alpha was 0.52 and, after the subtraction of the "cognitive fluctuation" criterion, was only 0.31. Accuracy, sensitivity, and specificity were higher for LBCRS vs. AT-DLB. However, when simultaneously considered in the logistic models, AT-DLB showed a better performance (p < 0.001). Overall, the concordance between LBCRS positive and AT-DLB possible/probable was of 78.02% CONCLUSIONS: In a clinical setting, the LBCRS and AT-DLB questionnaires have good accuracy for DLB diagnosis.

Identifiants

pubmed: 35244829
doi: 10.1007/s10072-022-05987-z
pii: 10.1007/s10072-022-05987-z
pmc: PMC9213280
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4221-4229

Subventions

Organisme : Italian Ministry of Health Research Grant Ricerca Finalizzata 2018
ID : RF-2018-12366209

Investigateurs

Baschi Roberta (B)
Fragiacomo Federica (F)
Galantucci Sebastiano (G)
Gaspari Caterina (G)
Gazzola Gianmarco (G)
Magnani Giuseppe (M)
Mazzon Giulia (M)
Mozzetta Stefano (M)
Ravanelli Carmela (R)
Ruggiero Marco (R)
Salute Pierpaolo (S)
Scamarcia Pietro Giuseppe (SP)
Turla Marinella (T)
Verde Federico (V)
Volontè Maria Antonietta (VM)

Informations de copyright

© 2022. The Author(s).

Références

Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Alzheimers Res Ther. 2018 Mar 1;10(1):27
pubmed: 29490691
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
Ann Neurol. 2016 Sep;80(3):368-78
pubmed: 27398636
Neurol Sci. 2017 Jan;38(1):83-91
pubmed: 27624723
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Alzheimers Res Ther. 2018 Feb 15;10(1):19
pubmed: 29448953
Acta Neurol Belg. 2021 Feb;121(1):219-223
pubmed: 32931000
Alzheimers Dement (Amst). 2015 Sep 1;1(3):316-324
pubmed: 26405688
Mov Disord. 2003 Jul;18(7):738-50
pubmed: 12815652
J Clin Sleep Med. 2013 May 15;9(5):475-80
pubmed: 23674939
Parkinsonism Relat Disord. 2010 Jul;16(6):388-92
pubmed: 20434939
Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):137-43
pubmed: 26340964
Br J Psychiatry. 2000 Sep;177:252-6
pubmed: 11040887
Int J Geriatr Psychiatry. 2018 Oct;33(10):1293-1304
pubmed: 30091150
Neurology. 2020 Apr 28;94(17):743-755
pubmed: 32241955

Auteurs

Mirella Russo (M)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Claudia Carrarini (C)

Department of Neuroscience, Imaging and Clinical Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Angelo Di Iorio (A)

Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Raffaello Pellegrino (R)

Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy.

Amalia Cecilia Bruni (AC)

Regional Neurogenetic Centre, Department of Primary Care, ASP-CZ, Lamezia Terme, Italy.

Salvatore Caratozzolo (S)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Annalisa Chiari (A)

U.O. Di Neurologia, Azienda Ospedaliera Universitaria Di Modena, Modena, Italy.

Stefano Pretta (S)

Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Camillo Marra (C)

Memory Clinic, Fondazione Policlinico Gemelli, IRCCS Università, Cattolica del Sacro Cuore, Rome, Italy.

Maria Sofia Cotelli (MS)

UO Neurologia ASST Valcamonica, Brescia, Italy.

Andrea Arighi (A)

UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Giorgio G Fumagalli (GG)

UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.

Tatiana Cataruzza (T)

Department of Medicine, Surgery and Health Sciences, Neurology Unit, University Hospital and Health Services of Trieste, Trieste, Italy.

Francesca Caso (F)

Unit of Neurology, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Cristina Paci (C)

Division of Neurology, Ospedale Madonna del Soccorso, ASUR Marche, San Benedetto del Tronto-Ascoli, Piceno, Italy.

Mara Rosso (M)

Neurology Clinic, SS Annunziata Hospital of Savigliano, Savigliano, Italy.

Serena Amici (S)

Cognitive Disorder and Dementia Unit, USL Umbria 1, Perugia, Italy.

David Giannandrea (D)

Neurologia E Stroke Unit, Ospedale Di Gubbio E Gualdo Tadino, Perugia, Italy.

Andrea Pilotto (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Simona Luzzi (S)

Department of Experimental and Clinical Medicine, Polytechnic University of Marche - Ospedali Riuniti, Ancona, Italy.

Annalisa Castellano (A)

CDCD IRCSS Neuromed Di Pozzilli, Isernia, Italy.

Fabrizia D'antonio (F)

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.

Antonina Luca (A)

Department of Medical, Surgical Sciences and Advanced Technologies, GF Ingrassia, University of Catania, Catania, Italy.

Giorgio Gelosa (G)

Cognitive Neuropsychology Center, Niguarda Hospital, Milan, Italy.

Tommaso Piccoli (T)

Unit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Marco Mauri (M)

Department of Biotechnologies and Life Sciences, University of Insubria, Varese, Italy.

Federica Agosta (F)

Unit of Neurology, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.

Claudio Babiloni (C)

Department of Physiology and Pharmacology "V. Erspamer, Sapienza University of Rome, Rome, Italy.
Hospital San Raffaele Cassino (FR), Cassino, Italy.

Barbara Borroni (B)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Marco Bozzali (M)

Department of Neuroscience, University of Turin, Turin, Italy.

Massimo Filippi (M)

Unit of Neurology, Neuroimaging Research Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milan, Italy.

Daniela Galimberti (D)

UOSD Neurologia, Malattie Neurodegenerative, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.

Roberto Monastero (R)

Section of Neurology, Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.

Cristina Muscio (C)

Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Lucilla Parnetti (L)

Laboratory of Clinical Neurochemistry, Section of Neurology, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.

Daniela Perani (D)

In Vivo Human Molecular and Structural Neuroimaging Unit, Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Laura Serra (L)

Neuroimaging Laboratory, Fondazione Santa Lucia, IRCCS, Rome, Italy.

Vincenzo Silani (V)

Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano and Università Degli Studi Di Milano, Milano, Italy.

Pietro Tiraboschi (P)

Neurology 5-Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Annachiara Cagnin (A)

Department of Neurosciences, University of Padova, Padova, Italy.

Alessandro Padovani (A)

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Laura Bonanni (L)

Department of Medicine and Aging Sciences, University G. d'Annunzio of Chieti-Pescara, Chieti, Italy. l.bonanni@unich.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH